M&A Deal Summary

Debiopharm International SA Acquires Spinomix - FibroTrap Sample Processing Technology

On June 16, 2015, Debiopharm International SA acquired information technology company Spinomix - FibroTrap Sample Processing Technology from Spinomix SA

Acquisition Highlights
  • This is Debiopharm International SA’s 1st transaction in the Information Technology sector.
  • This is Debiopharm International SA’s 1st transaction in the United States.

M&A Deal Summary

Date 2015-06-16
Target Spinomix - FibroTrap Sample Processing Technology
Sector Information Technology
Buyer(s) Debiopharm International SA
Sellers(s) Spinomix SA
Deal Type Divestiture

Target

Spinomix - FibroTrap Sample Processing Technology

United States
Spinomix - FibroTrap Sample Processing Technology is a fibrinogen-based technology allowing the highly specific separation and efficient concentration of target molecules from liquid samples within a simple, routine sample-collection tube.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Debiopharm International SA

Lausanne, Switzerland

Category Company
Founded 1979
Sector Life Science
DESCRIPTION

Debiopharm International SA is global biopharmaceutical group of four companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1

Seller(S) 1

SELLER

Spinomix SA

Lausanne, Switzerland

Category Company
Sector Information Technology
DESCRIPTION

Spinomix SA is a technology platform company providing innovative sample processing solutions to the life sciences sector.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1